Department of Pharmacognosy and Hydrology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
J Altern Complement Med. 2009 Nov;15(11):1239-42. doi: 10.1089/acm.2009.0304.
Osteoarthritis (OA) is characterized by progressive cartilage degradation and secondary inflammation of the synovial membrane. Studies have shown that mud therapy may influence serum levels of several cytokines involved in the pathogenesis of OA and chondrocyte metabolism. The main targets of our research were to make use of Lake Urmia mud for topical gel formulation, evaluation of the possible therapeutic effects of this gel on symptoms of patients with knee OA and the evaluation of serum tumor necrosis factor-alpha (TNF-alpha) level after mud therapy in comparison with the application of a placebo.
Fifty (50) patients suffering from knee OA participated in this study and randomized into two groups: case group and control group. Patients in the case group received mud therapy and the placebo was applied to patients in the control group. Three (3) parameters including pain, morning stiffness, and joint functionality were assessed in all patients. Visual analogue scale and Western Ontario McMaster Osteoarthritis index (WOMAC) were the employed scales for pain assessment. Functional capacity was evaluated by using WOMAC functional capacity and WOMAC global index. All the mentioned steps were done before and after treatment. Blood samples, in both groups, were collected for measuring tumor necrosis factor (TNF)-alpha serum level.
All the differences (for three parameters), in the case group, were statistically significant. TNF-alpha serum level reduction in both groups were detected: 19.41% in the case group and 1.76% in the control group.
Mud therapy using formulated gel is an effective method in knee OA treatment and pain reduction. Further studies may be needed for the evaluation of possible synergism between pharmacological treatment and mud therapy.
骨关节炎(OA)的特征是渐进性软骨降解和滑膜的继发性炎症。研究表明,泥疗可能会影响参与 OA 发病机制和软骨细胞代谢的几种细胞因子的血清水平。我们研究的主要目的是利用乌尔米亚湖泥制成局部凝胶制剂,评估这种凝胶对膝关节 OA 患者症状的可能治疗效果,并与安慰剂应用相比评估泥疗后血清肿瘤坏死因子-α(TNF-α)水平。
50 名患有膝关节 OA 的患者参加了这项研究,并随机分为两组:病例组和对照组。病例组接受泥疗,对照组应用安慰剂。所有患者均评估了 3 个参数,包括疼痛、晨僵和关节功能。视觉模拟评分和西部安大略省麦克马斯特大学骨关节炎指数(WOMAC)用于评估疼痛。采用 WOMAC 功能能力和 WOMAC 总体指数评估功能能力。所有这些步骤都在治疗前后进行。两组均采集血样,用于测量肿瘤坏死因子(TNF)-α血清水平。
病例组所有差异(三个参数)均具有统计学意义。两组的 TNF-α血清水平均降低:病例组降低 19.41%,对照组降低 1.76%。
使用配方凝胶进行泥疗是治疗膝关节 OA 和减轻疼痛的有效方法。可能需要进一步研究评估药物治疗与泥疗之间的协同作用。